Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B: 41 Adverse Event Reports & Safety Profile

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra
41
Total FAERS Reports
0
Deaths Reported
4
Hospitalizations
41
As Primary/Secondary Suspect
8
Disabilities

Active Ingredient: HYDROCORTISONE\OXYTETRACYCLINE HYDROCHLORIDE\POLYMYXIN B SULFATE ·

First Report: 19970830 · Latest Report: 20250219

What Are the Most Common HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B Side Effects?

#1 Most Reported
Hypoacusis
12 reports (29.3%)
#2 Most Reported
Deafness
11 reports (26.8%)
#3 Most Reported
Ear discomfort
7 reports (17.1%)

All HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hypoacusis 12 29.3% 0 0
Deafness 11 26.8% 0 0
Ear discomfort 7 17.1% 0 0
Tinnitus 6 14.6% 0 1

Who Reports HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B Side Effects? Age & Gender Data

Gender: 49.0% female, 51.0% male. Average age: 55.6 years. Most reports from: SE. View detailed demographics →

Is HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 2 0 1
2015 1 0 0
2016 3 0 2
2017 4 0 0
2018 4 0 0
2019 5 0 0
2020 3 0 0
2021 2 0 0
2022 3 0 0
2023 3 0 0
2024 1 0 0
2025 1 0 0

View full timeline →

What Is HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B Used For?

IndicationReports
Ear infection 9
Eczema 6
Otitis externa 6

Official FDA Label for HYDROCORTISONE\OXYTETRACYCLINE\POLYMYXIN B

Official prescribing information from the FDA-approved drug label.